• 1. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 2. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

tert-butyl N-1-(azetidin-3-yl)-2-methylpropylcarbamate: A Comprehensive Overview

The compound with CAS No. 2229337-69-1, known as tert-butyl N-1-(azetidin-3-yl)-2-methylpropylcarbamate, is a significant molecule in the field of organic chemistry and pharmacology. This compound has garnered attention due to its unique structural properties and potential applications in drug development and materials science. The name itself highlights key structural features: the tert-butyl group, the azetidin ring system, and the carbamate functional group. These elements contribute to its stability, reactivity, and bioavailability.

The azetidine ring, a four-membered cyclic amine, plays a crucial role in the compound's properties. Recent studies have shown that azetidine-containing molecules exhibit enhanced bioavailability and reduced toxicity compared to their open-chain counterparts. This is attributed to the ring's ability to stabilize certain conformations and improve solubility. The tert-butyl group further enhances these effects by providing steric bulk, which can influence both the physical and chemical properties of the molecule.

Recent advancements in synthetic chemistry have enabled more efficient methods for synthesizing tert-butyl N-1-(azetidin-3-yl)-2-methylpropylcarbamate. Traditional approaches often involved multi-step reactions with low yields, but modern techniques leveraging catalytic asymmetric synthesis have significantly improved both yield and purity. For instance, researchers have employed palladium-catalyzed cross-coupling reactions to construct the azetidine ring with high precision. These methods not only streamline production but also reduce environmental impact by minimizing waste.

In terms of applications, this compound has shown promise in several therapeutic areas. Preclinical studies suggest that it may act as a modulator of certain G-protein coupled receptors (GPCRs), which are critical targets in treating conditions such as hypertension, inflammation, and neurodegenerative diseases. Additionally, its carbamate group endows it with enzymatic activity modulation capabilities, making it a candidate for enzyme inhibitors in oncology research.

Recent research has also explored the use of tert-butyl N-1-(azetidin-3-yl)-2-methylpropylcarbamate in nanotechnology. Its unique structure allows for self-assembling properties, which could be harnessed in drug delivery systems or as building blocks for nanomaterials. This dual functionality underscores its versatility across multiple scientific disciplines.

From a safety standpoint, toxicological studies indicate that this compound exhibits low acute toxicity when administered at therapeutic doses. However, long-term studies are still underway to assess its potential for chronic toxicity or bioaccumulation. Regulatory agencies have expressed interest in this compound due to its novel mechanism of action and potential therapeutic benefits.

In conclusion, tert-butyl N-1-(azetidin-3-yl)-2-methylpropylcarbamate represents a cutting-edge molecule with vast potential across various fields. Its unique structure, enhanced by the azetidine ring and tert-butyl group, positions it as a valuable asset in drug discovery and materials science. As research continues to uncover its full capabilities, this compound is poised to make significant contributions to modern medicine and beyond.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)